JUPITER NEUROSCIENCES, INC. Increase (Decrease) in Accounts Receivable
JUPITER NEUROSCIENCES, INC. (JUNS) reported Increase (Decrease) in Accounts Receivable of $7.60 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-14
- JUPITER NEUROSCIENCES, INC. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $10.24K.
- JUPITER NEUROSCIENCES, INC. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was -$2.64K.
- JUPITER NEUROSCIENCES, INC. increase (decrease) in accounts receivable for fiscal 2025 was $2.64K.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|
| 2026-06-30 | $10.24K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $7.60K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | -$2.64K 10-Q · filed 2026-05-14 | ||
| 2025-12-31 | $2.64K 10-K · filed 2026-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |